Naftidrofuryl
Clinical data | |
---|---|
Trade names | Praxilene |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Elimination half-life | 1 - 3.5 hours |
Identifiers | |
| |
JSmol) | |
| |
| |
(verify) |
Naftidrofuryl (
peripheral arterial disease
.
Naftidrofuryl is marketed under a variety of trade names, including Artocoron, Azunaftil, Di-Actane, Dusodril, Enelbin, Frilix, Gevatran, Iridus, Iridux, Luctor, Nafti, Naftilong, Naftodril, Nafoxal, Praxilene, Sodipryl retard, and Vascuprax.
Historically, it has been used to treat sudden
Naftidrofuryl may be effective for relieving the pain of muscle cramps.[5]
Adverse Effects
Naftidrofuryl has been associated with nausea, abdominal pain and rash. Rarely, hepatitis and liver failure have been reported.[6]
See also
References
- ISBN 978-3-642-56225-9.
- ISBN 978-94-011-4439-1.
- PMID 19672037.
- ^ "DER ARZNEIMITTELBRIEF: Infusionstherapie beim idiopathischen Hörsturz? Dextran Dextran Hörsturz Hydroxyethylstärke Pentoxifyllin Pentoxifyllin Procain Taprosten". www.der-arzneimittelbrief.de.
- PMID 20177124.
- ^ Brayfield A, ed. (14 January 2014). "Naftidrofuryl Oxalate". Martindale: The Complete Drug Reference. Pharmaceutical Press. Retrieved 6 August 2014.